Could you please explain which "shocking disclosures" have a "strong probability" of constituting a Material Adverse Event in relation to Sumitomo's acquisition of Nufarm's South American business? I've scoured the recent press from Nufarm and find precisely nothing that raises even the suspicion of such an event or that might otherwise be "fatally bad" for Nufarm.
The $9 million in omitted incentive payments arose in Germany and has nothing to do with South America. It's utterly irrelevant to the sale.
While a negative for the business, the adverse headwinds are also either (i) irrelevant because they mostly affect the Australian and North American businesses and/ore (ii) to the extent that they do affect the South American business fall a million miles short of constituting a Material Adverse Event to the transaction and, in any event, would have been largely known to Sumitomo and, therefore, factored into the negotiated price.
I'm happy to change my mind if you can explain why my views are wrong but, so far, I'm not seeing anything that would put completion of the sale at risk or others be "fatally bad" to Nufarm.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)